Trump Administration Releases New COVID-19 Vaccine Plan
Digest more
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few days of dosing. None of the companies involved have commented on the change in the warning text.
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
1️⃣ Grim warning: The world’s ice sheets are on course for runaway melting, leading to multiple feet of sea level rise and “catastrophic” migration. The dire prognosis from a group of international scientists suggests that coastlines will pay the heaviest price .
Explore more
Gov. Josh Green on Wednesday defended COVID-19 vaccines before a U.S. Senate subcommittee in Washington, D.C., saying they saved countless lives during the pandemic.